TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06382883

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individually tailored lifestyle and physical activity intervention
Description: Focus of the SEMC-protocol is on increasing PA gradually towards the national recommendations. Emphasis of counseling is on incidental exercise, endurance, and strength training. Techniques of motivational interviewing are utilized.~Baseline; MD+PT counseling, medical clearance, mapping lifestyle \& life situation, goal setting, measurements, questionnaires, feedback. weeks 1-6: guided group resistance training 1hr, 1x/week. 5-10-minute warm-up, 9 exercises with weight stack equipment on large muscle groups. 2-3 sets, 12-15 repetitions. Modified individually, e.g. according to musculoskeletal problems. Emphasis on learning the basics and safety aspects. After 6 weeks unsupervised training. 3-month: MD counseling and questionnaires. 6-month: MD+PT counseling, assessing safety of PA, measurements, questionnaires, feedback. 12-month: MD+PT counseling (feedback, ensuring continuity of lifestyle changes; redirecting to municipality/NGO activities), measurements, questionnaires, feedback

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individually tailored lifestyle and physical activity intervention combined with enhanced behavioral support -intervention (EBS)
Description: In addition to the SEMC-protocol, the participants will be contacted 3 times during the first 3 months (live / online as preferred). Themes:~Session 1: Motivation and illness perceptions. Exploring CPAP use, PA, and SB. Session 2: Self-regulation (feedback, goal setting, self-monitoring, action planning, problem solving), activating social support, prompts/cues, and preparatory behaviors. (Included BCTs from Michie et al 2013 taxonomy: 3.2, 12.2, 8.3,) Session 3: Assessing progress and agenda setting, self-regulation, maintenance of PA.~Measurements and questionnaires as with SEMC-protocol.
Study: NCT06234332

Intervention type: OTHER
Intervention: No Interventions
Description: No intervention This is an observational study without any intervention
Study: NCT04887480

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Abthera™ Open Abdomen Negative Pressure Therapy Device System
Description: Suction set at -125mmHg

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Abthera™ Open Abdomen Negative Pressure Therapy Device System
Description: Suction set at -125mmHg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dianeal PD-2 with 2.5% Dextrose
Description: 800mL to 1000mL of Dianeal PD-2 into Abthera™ and dwell for 1 hour.
Study: NCT05659381

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin 100mg/m2 IP over 90 minutes at 42 degrees Celcius

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No treatment
Description: No treatment with Cisplatin
Study: NCT06067243

Intervention type: DIAGNOSTIC_TEST
Intervention: T2 mapping 3T MRI + hip arthroscopy
Description: 1. 3T MRI~2. hip arthroscopy
Study: NCT04804605

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
Description: ARQ-151 Cream
Study: NCT05654922

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARINA-1
Description: ARINA-1 (88 mg/mL ascorbic acid, ASC; 150 mg/mL reduced glutathione, GSH)

Intervention type: OTHER
Group type: OTHER
Intervention: Standard of care only
Description: Standard 3-therapy immunosuppression regimen and azithromycin
Study: NCT04081298

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Education
Description: Attend nutrition and PA classes, and cooking sessions

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Activity
Description: Participate in physical activities

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Promotion and Education: Text Messages
Description: Receive motivational text messages

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Promotion and Education: Web Site
Description: Given access to nutrition website

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT06355908

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IL13Rα2 CAR-T
Description: The IL13Rα2 CAR-T cells will be administered via intraventricular infusion every 2 weekly via an Ommaya reservoir.
Study: NCT04888481

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-HA-DOTATATE
Description: Tracer injection
Study: NCT04977947

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Eating for My Infant
Description: The intervention targets problem solving to overcome barriers, behavioral rehearsal and practice of healthy behaviors, promoting readiness to change, goal setting, self-monitoring, and behavioral tracking. Two standard treatment modules will be provided to each family by a study interventionist focusing on infant nutritional requirements, responsive feeding, and mealtime behaviors. Two additional treatment modules will be selected to address the unique needs articulated by each family (e.g., food insecurity, eating healthy on a limited income, emotional eating, engaging other caregivers, maternal mental health). Modules will consider the influence of maternal trauma history and mental health on feeding and eating behavior. The intervention also includes two peer counselor-led sessions during which families can discuss implementation of recommendations and barriers to change with a member of their community who can problem solve and support change.
Study: NCT04782765

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab+Chemotherapy+Chemoradiotherapy
Description: Patients received neoadjuvant Camrelizumab 200mg combined with chemotherapy (Cisplatin 20mg/m2, Day 1-3, Docetaxel 75mg/m2, Day 1) for 2 cycles every 21 days, followed by concurrent chemoradiotherapy with Camrelizumab monotherapy maintenance
Study: NCT05805865

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Toothpaste Tablet
Description: Colgate Anywhere Toothpaste Tablets

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Toothpaste
Description: Colgate Cavity Protection
Study: NCT05324098

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: STAND-T platform
Description: Internet-based intervention comprised of evidence-based, patient materials and resources

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Satisfaction and follow-up surveys will be administered to participants

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Text Messages
Description: Participants will receive periodic text messages
Study: NCT05244798

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Sintilimab: D1 administration) for 2 cycles. Every 3 weeks was a dosing cycle (Q3W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Sintilimab: D1 administration) for 2 cycles. Every 3 weeks was a dosing cycle (Q3W)

Intervention type: RADIATION
Group type: OTHER
Intervention: radiotherapy
Description: Radiotherapy: According to IMRT treatment plan, the total dose was 41.4Gy, divided into 23 times, 5 days a week.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: Radiotherapy: According to IMRT treatment plan, the total dose was 41.4Gy, divided into 23 times, 5 days a week.

Intervention type: DRUG
Group type: OTHER
Intervention: Chemotherapy
Description: Neoadjuvant chemotherapy with TP regimen: albumin-paclitaxel + carboplatin, D1 administration) for 2 cycles. Every 3 weeks was a dosing cycle (Q3W).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Neoadjuvant chemotherapy with TP regimen: albumin-paclitaxel + carboplatin, D1 administration) for 2 cycles. Every 3 weeks was a dosing cycle (Q3W).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Neoadjuvant chemotherapy with TP regimen: albumin-paclitaxel + carboplatin, D1 administration) for 2 cycles. Every 3 weeks was a dosing cycle (Q3W).
Study: NCT05265754

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sujok therapy
Description: sujok therapy
Study: NCT05404659

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oscillatory Mobilization
Description: conventional physical therapy treatment, postural correction and maitland's oscillatory mobilizitions.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mckenzie Retraction Exercises
Description: conventional physical therapy treatment, postural correction and Mckenzie retraction exercises.
Study: NCT06057740

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy (ACT)
Description: ACT is a psychological intervention that aims to improve psychological flexibility, the ability to hold thoughts and emotions lightly in a given context and pursue valued ends (Hayes et al., 1999; Twohig \& Levin, 2017).
Study: NCT01239017

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: REGN475

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: REGN475

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: REGN475
Study: NCT06413641

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Follow up at GP
Description: As described before
Study: NCT01239017

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: REGN475

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT04455139

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topotecan
Description: intravitreal or intra-arterial administration of topotecan

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topotecan
Description: intravitreal or intra-arterial administration of topotecan

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melphalan
Description: intravitreal or intra-arterial administration of topotecan

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melphalan
Description: intravitreal or intra-arterial administration of topotecan

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: intravitreal or intra-arterial administration of topotecan
Study: NCT03522545

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)
Description: Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) isolated from hematogenous bone marrow

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)
Study: NCT05474820

Intervention type: OTHER
Group type: OTHER
Intervention: Samples collection and ELISA analyses
Description: The serum and unstimulated saliva samples were taken from all patients between 8:00 and 10:00 in the morning. Saliva samples were centrifuged at 10,000 rpm (10 min) whereas venous blood samples were centrifuged at 4000 rpm for 10 min.~For the analysis of irisin and IL-6 specific ELISA Kits (Elabscience, Houston, Texas, USA) were used to determine the molecules in both serum and saliva samples in accordance with the manufacturer's instructions. All samples were run in duplicate, and values have been averaged.

Intervention type: OTHER
Group type: OTHER
Intervention: Samples collection and ELISA analyses
Description: The serum and unstimulated saliva samples were taken from all patients between 8:00 and 10:00 in the morning. Saliva samples were centrifuged at 10,000 rpm (10 min) whereas venous blood samples were centrifuged at 4000 rpm for 10 min.~For the analysis of irisin and IL-6 specific ELISA Kits (Elabscience, Houston, Texas, USA) were used to determine the molecules in both serum and saliva samples in accordance with the manufacturer's instructions. All samples were run in duplicate, and values have been averaged.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Evaluating periodontal paramètres
Description: The clinical periodontal parameters (plaque index (PI), probing pocket depth (PD), gingival recession (GR), clinical attachment loss (CAL), and bleeding on probing (BOP)) were recorded on periodontal charts in each patient

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Evaluating periodontal paramètres
Description: The clinical periodontal parameters (plaque index (PI), probing pocket depth (PD), gingival recession (GR), clinical attachment loss (CAL), and bleeding on probing (BOP)) were recorded on periodontal charts in each patient
Study: NCT05098990

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jinfukang oral liquid
Description: Jinfukang koufuye is a Chinese herbal prescription, which is used in treatment for patients with NSCLC in clinical practice. It has been proved to be capable of preventing the occurrence of metastasis, stabilizing tumor lesions, improving the response rates when combined with chemotherapy, and prolonging the survival period of lung cancer patients.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Platinum-based doublet chemotherapy
Description: Platinum-based doublet chemotherapy as first line therapy has been shown to be efficacious against non-small cell lung cancer.
Study: NCT06494163

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The MICT and HIIT intervention groups will complete supervised virtual exercise sessions for 12 weeks using Zoom care or Microsoft Teams as a backup resource. The appointments will be scheduled and conducted 2 days per week. Initially, exercise intensity will be determined from participants' peak HR achieved during a baseline CPET.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The MICT and HIIT intervention groups will complete supervised virtual exercise sessions for 12 weeks using Zoom care or Microsoft Teams as a backup resource. The appointments will be scheduled and conducted 2 days per week. Initially, exercise intensity will be determined from participants' peak HR achieved during a baseline CPET.
Study: NCT06367179

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality and AI use
Description: The experimental group will receive interventions of virtual reality and artificial intelligence wound detecting system.

Intervention type: OTHER
Group type: OTHER
Intervention: Health education leaflet
Description: The control group maintained the traditional pressure injury health education with oral introduction and health education leaflet.
Study: NCT05787223

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Baseline Treatment
Description: Control Group that will be provided with be given baseline treatment of static balance training (static exercise like standing on balance board, bounce on one foot, heel rises/toe rises, standing on one foot, jumping on trampoline)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baseline Treatment
Description: Control Group that will be provided with be given baseline treatment of static balance training (static exercise like standing on balance board, bounce on one foot, heel rises/toe rises, standing on one foot, jumping on trampoline)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic Training
Description: Experimental Group that will be provided with base line treatment along with dynamic balance training (cross, side \&tandem walking, step up and down, jumping \&hopping on floor). Exercises Will be given the 40 minutes with 2 sessions per week over the period of 08 weeks
Study: NCT05312203

Intervention type: OTHER
Group type: OTHER
Intervention: the App
Description: The App provides content for mobile-based stress relief that can be used on most Android and iOS-based mobile devices. Content for stress relief consists of three modules; meditation, cognitive approach, and relaxation sounds. Additionally, the App includes the module for objective stress monitoring. The APP was originally designed and developed in Korean, but English, Chinese, and Japanese versions are also available. For use in the treatment environment, the manufacturer also provides a service that allows therapists to check their patients' application usage and their stress level measured by the stress monitoring module.

Intervention type: OTHER
Group type: OTHER
Intervention: the App
Description: The App provides content for mobile-based stress relief that can be used on most Android and iOS-based mobile devices. Content for stress relief consists of three modules; meditation, cognitive approach, and relaxation sounds. Additionally, the App includes the module for objective stress monitoring. The APP was originally designed and developed in Korean, but English, Chinese, and Japanese versions are also available. For use in the treatment environment, the manufacturer also provides a service that allows therapists to check their patients' application usage and their stress level measured by the stress monitoring module.
Study: NCT04664309

Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study: NCT05309005

Intervention type: BEHAVIORAL
Intervention: VR TASIT
Description: Consists of a Norwegian adaptation of the 59 videos of social scenes that constitute the A Form in the original TASIT. The stimulus material in the Virtual Reality version is perceived through a head mounted display. This allows the test person to watch the scenes in three dimensions and a 360 degree angle, increasing the sense of social presence.

Intervention type: BEHAVIORAL
Intervention: VR TASIT
Description: Consists of a Norwegian adaptation of the 59 videos of social scenes that constitute the A Form in the original TASIT. The stimulus material in the Virtual Reality version is perceived through a head mounted display. This allows the test person to watch the scenes in three dimensions and a 360 degree angle, increasing the sense of social presence.

Intervention type: BEHAVIORAL
Intervention: DT TASIT
Description: Consists of a Norwegian adaptation of the 59 videos of social scenes that constitute the A Form in the original TASIT, with identical content as the VR TASIT. The stimulus material in the desktop version is perceived on a two dimensional desktop computer screen.

Intervention type: BEHAVIORAL
Intervention: DT TASIT
Description: Consists of a Norwegian adaptation of the 59 videos of social scenes that constitute the A Form in the original TASIT, with identical content as the VR TASIT. The stimulus material in the desktop version is perceived on a two dimensional desktop computer screen.
Study: NCT05793944

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SmartMom text messaging
Description: SmartMom is a mobile health program delivered via text messaging that guides participants through each week of pregnancy. Participants receive three messages per week with links to content focused on improving knowledge, providing information about prenatal assessments and screening, and encouraging the adoption of behaviours to support healthy pregnancy and physiologic birth. Messages are consistent with current professional guidelines and peer reviewed prenatal education curricula. SmartMom provides optional supplemental streams for individuals who wish to have additional messages addressing topics such as reducing use of tobacco, alcohol or illicit drugs, depression, obesity, and maternal age over 35.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control text messaging
Description: Control arm participants will receive weekly text messages with accurate, general-interest information about pregnancy and about progress of the trial. Content is not geared to decision-making during pregnancy that may affect health outcomes.
Study: NCT06413641

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Consultation
Description: As described before

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Consultation
Description: As described before

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visualization of CTA images
Description: As described before
Study: NCT04938167

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 95% - 99% SpO2 target
Description: If the infant is randomized to the intervention arm, the oxygen saturation goal will be changed from the standard goal of 91% - 95% to the experimental goal of 95%-99%. The treating medical team will then adjust the oxygen and respiratory support to maintain these goals (SpO2 alarm levels will be set at 93% and 100%).
Study: NCT05168150

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: Experimental Group - Intelligent Continuous Expertise Monitoring System group
Description: During each of the practice task they will receive real-time auditory feedback instructed by the intelligent system. After each attempt, a student takes a 5-minute break. They will be shown the errors they made during the task regarding five performance metrics. After seeing each error, they will be shown video demonstration to learn how to expertly perform at each performance metrics. On their 6th attempt they will perform on the realistic scenario without any feedback given.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental Group In-person expert-mediated instruction group
Description: During each of the practice task, students will receive verbal feedback from the expert instructor present in the room. After each task, experts will summarize their performance and outline the errors the student made. Based on the student's performance, expert will demonstrate how to expertly perform the task in the simulation, and how to improve their performance in the next attempt. Students will perform the 6th attempt on the realistic scenario without any instruction given.
Study: NCT04790201

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Friendship Bench Delivered by Professional Counselor
Description: Participants randomized to this arm will receive the Friendship Bench protocol delivered by a professional counselor.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Friendship Bench Delivered by Lay Counselor
Description: Participants randomized to this arm will receive the Friendship Bench protocol delivered by a trained lay counselor.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: Enhanced usual care (EUC) will include general training of the HIV providers and clinics about CMD identification and management, and feedback to the HIV provider of the status of their enrolled patient to allow follow-up per the clinic's standard care. Information will be collected in follow-up interviews to characterize the care that patients receive. These activities will occur in all three arms, but they are the only activities in the EUC arm.
Study: NCT04428944

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wide Circumferential Pulmonary Vein Antrum Isolation (PVAI)
Description: Standard PVI

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary Vein Antrum Isolation Plus Driver Ablation (PVAI+drivers)
Description: Standard PVI + Ablation of drivers in LA and RA

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary Vein Antrum Isolation Plus Box Isolation of Posterior Wall (PVAI+box)
Description: Standard PVI + Electrical isolation of the posterior wall of the left atrium